Details of the Drug

General Information of Drug (ID: DMZSGPB)

Drug Name
N-(5-Hydroxycarbamoyl-pentyl)-benzamide
Synonyms CHEMBL143849; N-(5-Hydroxycarbamoyl-pentyl)-benzamide; SCHEMBL1232912; BDBM50082658; ZINC13801954; M-354
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 250.29
Logarithm of the Partition Coefficient (xlogp) 0.6
Rotatable Bond Count (rotbonds) 7
Hydrogen Bond Donor Count (hbonddonor) 3
Hydrogen Bond Acceptor Count (hbondacc) 3
Chemical Identifiers
Formula
C13H18N2O3
IUPAC Name
N-[6-(hydroxyamino)-6-oxohexyl]benzamide
Canonical SMILES
C1=CC=C(C=C1)C(=O)NCCCCCC(=O)NO
InChI
InChI=1S/C13H18N2O3/c16-12(15-18)9-5-2-6-10-14-13(17)11-7-3-1-4-8-11/h1,3-4,7-8,18H,2,5-6,9-10H2,(H,14,17)(H,15,16)
InChIKey
WOSZGUVOSPLDAN-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
9921260
TTD ID
D08PMD

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Histone deacetylase (HDAC) TTBH0VX NOUNIPROTAC Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Amide analogues of trichostatin A as inhibitors of histone deacetylase and inducers of terminal cell differentiation. J Med Chem. 1999 Nov 4;42(22):4669-79.